Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Single-molecule tracking for live-cell protein synthesis kinetics

Project description

Unveiling the molecular determinants of in vivo protein synthesis

Correct protein synthesis, targeting and folding is paramount for all living cells. With an increasing demand for therapeutic proteins such as antibodies, there is an urgent need to understand and control the molecular mechanisms responsible for this process. The EU-funded SMACK project will investigate how the mRNA sequence ultimately determines how, where, and when a polypeptide folds. Using a fluorescence-based experimental and analytical system, scientists will analyse kinetics of protein synthesis at the single molecule level directly inside the living cell, as well as how clinically relevant antibiotic drugs inhibit this process. The generated knowledge will provide clues regarding the design of microbial-based protein production systems, as well as the design of new antibiotic drugs.

Objective

This project aims to map the determinants of efficient synthesis, folding, and targeting of proteins in living bacterial cells, and to understand how antibiotic drugs inhibit these events. Our findings will be used to form a quantitative description of how the mRNA sequence ultimately determines how, where, and when a polypeptide should fold, which will help to design better E. coli-based production systems for recombinant proteins; both protein folding and targeting are currently severe bottlenecks. Further, by studying the effect of clinically relevant antibiotic drugs directly on ongoing protein synthesis, we will learn how the inhibitory action on the molecular level is translated into the response on cell and population level. This knowledge will help to improve the use of current drugs, as well as to provide clues regarding how new drugs should be designed.

To reach our goals, we will use and further develop our recently published fluorescence-based experimental and analytical system for live-cell single-molecule analysis of protein synthesis kinetics. Particularly, we will develop orthogonal translation systems to measure protein synthesis kinetics on defined mRNAs in an unperturbed cell background. We will also label and study key components of the universal pathway for Signal Recognition Particle-mediated cotranslational targeting of peptides to the membrane-bound peptide translocation complexes. In these applications we use small organic dyes for site-specific labeling of molecules, which allow recording of long diffusion trajectories inside cells. These trajectories are then fed to our machine-learning algorithms to deduce the binding kinetics.

With an increasing demand for therapeutic proteins, such as monoclonal antibodies for cancer treatment, there is an urgent need for microbial-based systems for cost-effective production of recombinant proteins. With our unique experimental and analytical system, we have the opportunity to aid in this development.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

ERC-STG - Starting Grant

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2020-STG

See all projects funded under this call

Host institution

UPPSALA UNIVERSITET
Net EU contribution
€ 1 653 550,00
Address
VON KRAEMERS ALLE 4
751 05 Uppsala
Sweden
Region
Östra Sverige Östra Mellansverige Uppsala län
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 1 653 550,00

Beneficiaries (1)